Anish Thomas, M.D.

Trials

Studies that name Anish Thomas, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:04 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT07328490 · Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer

  National Cancer Institute (NCI) · withdrawn · Extensive-Stage Small Cell Lung Cancer, Extrapulmonary Neuroendocrine Carcinoma, Small Cell Carcinoma · principal investigator
• Ph1/Ph2
  NCT04826341 · A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors

  National Cancer Institute (NCI) · completed · HRD Cancer, SCLC, Advanced Solid Tumors · principal investigator
• Ph1/Ph2
  NCT04802174 · Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers

  National Cancer Institute (NCI) · active not recruiting · SCLC, Small Cell Cancer, Advanced Solid Tumor · principal investigator
• Ph1/Ph2
  NCT03554473 · M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

  National Cancer Institute (NCI) · completed · Carcinoma, Small Cell, Lung Cancer, Small Cell Lung Cancer · principal investigator
• Ph1/Ph2
  NCT02769962 · Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

  National Cancer Institute (NCI) · terminated · Urothelial Carcinoma, Urothelial Cancer, Lung Neoplasms · principal investigator
• Ph1/Ph2
  NCT02487095 · Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers

  National Cancer Institute (NCI) · completed · Carcinoma, Non-Small -Cell Lung, Ovarian Neoplasms, Small Cell Lung Carcinoma · principal investigator
• N/A
  NCT01851395 · Rapid Autopsy and Procurement of Cancer Tissue

  National Cancer Institute (NCI) · terminated · Thymus Tumors, Adoptive Cellular Therapy, Mesothelioma · principal investigator
• Ph1
  NCT00926640 · A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers

  National Cancer Institute (NCI) · completed · Carcinoma Neuroendocrine, Small Cell Lung Carcinoma, Malignant Epithelial Neoplasms · principal investigator
• Ph1
  NCT00923520 · A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies

  National Cancer Institute (NCI) · completed · Renal Cell Carcinoma, Breast Cancer, Colon Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.